August 22, 2017 9:13 PM ET

Healthcare Equipment and Supplies

Company Overview of Amedica Corporation

Company Overview

Amedica Corporation, a commercial-stage biomaterial company, develops, manufactures, and sells a range of medical devices based on its silicon nitride ceramic technology platform in the United States, Europe, and South America. The company offers Valeo silicon nitride spinal fusion devices for use in the cervical and thoracolumbar areas of the spine; and a line of non-silicon nitride spinal surgery products for the treatment of deformity and degenerative spinal procedures. It also develops femoral heads for use in total hip replacements; and femoral condyle components for use in total knee replacements. The company markets and sells its products to surgeons and hospitals directly, as well as...

1885 West 2100 South

Salt Lake City, UT 84119

United States

Founded in 1996

56 Employees

Phone:

801-839-3500

Key Executives for Amedica Corporation

Chairman of The Board, CEO, President & Principal Financial Officer
Age: 55
Total Annual Compensation: $409.6K
Chief Technology Officer
Age: 65
Total Annual Compensation: $257.4K
Compensation as of Fiscal Year 2015.

Amedica Corporation Key Developments

Amedica Corporation announced delayed 10-Q filing

On 08/16/2017, Amedica Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

Amedica Corporation Reports Unaudited Earnings Results for the Fourth Quarter and Full Year Ended of December 31, 2016

Amedica Corporation reported unaudited earnings results for the fourth quarter and full year ended of December 31, 2016. For the quarter, the company reported preliminary revenue of $3.7 million for the fourth quarter of 2016. Preliminary GAAP net loss was $0.16 per share, compared to net loss of $0.57 per share in the fourth quarter of 2015. For the full year, the company reported preliminary revenue of $15.2 million for the full year. The company reported preliminary GAAP net loss of $1.19 per share, compared to a net loss of $5.50 per share in 2015.

Amedica Receives Non-Compliance Letter From The NASDAQ

Amedica Corporation announced that it has delayed the filing of its Quarterly Report on Form 10-Q for the quarter ended March 31, 2017 ("Form 10-Q"). Because the filing of the Company's Form 10-Q has been delayed beyond the 5-day extension period of Form 12b-25, on May 23, 2017, Amedica received a written notice from the Listing Qualifications Department of The Nasdaq Stock Market ("NASDAQ") indicating that the Company is not in compliance with Listing Rule 5250(c)(1) because the Company has failed to file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2017. Under the NASDAQ Listing Rules, because the Company is also delinquent on filing its Annual Report on Form 10-K for the period ended December 31, 2016, the Company has until June 19, 2017 to submit a plan to NASDAQ as to how it plans to regain compliance with NASDAQ's continued listing requirements. If the Company is still unable to file its Form 10-K and Form 10-Q by that time, then the Company intends to submit a compliance plan on or prior to that date. If NASDAQ accepts the Company's plan, NASDAQ can grant an exception of up to 180 calendar days from the filing's due date, or until September 27, 2017, to regain compliance. The Company may regain compliance at any time during this 180-day period upon filing with the SEC its Form 10-K and Form 10-Q, as well as all subsequent required periodic financial reports that are due within that period. If NASDAQ does not accept the Company's plan, Amedica will have the opportunity to appeal that decision to a NASDAQ Hearings Panel. The NASDAQ notification letter has no immediate effect on the listing of Amedica's common stock on the NASDAQ Capital Market.

Similar Private Companies By Industry

Company Name Region
.decimal, Inc. United States
20/20 GeneSystems Inc. United States
20/20 Imaging LLC United States
21st Century Scientific, Inc. United States
21X Corporation United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
July 28, 2017
--
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States
Bertelsmann AG Europe
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Amedica Corporation, please visit www.amedica.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.